▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #304 by analyst upside · 2026-08-13
CDXS
Codexis, Inc.
Healthcare · Market Cap $172M · P/E 0x
ANALYST PRICE TARGET
+311.5%
implied upside to consensus target
Current Price $1.6
Consensus Target $6.58
Bull Target $11.0
Bear Target $2.0
Analysts Covering 6
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
3
Hold
2
Sell
0
52-Week Low $0.96
52-Week High $3.87
YTD Return -0.6%
FUNDAMENTALS
Market Cap $172M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-0.36
PEG Ratio 13.53
Dividend Yield N/A
Revenue (TTM) $78M
Profit Margin -41.0%
52-WEEK RANGE
52-Week Low $0.96
52-Week High $3.87
Current Price $1.6
Bear Target $2.0
Bull Target $11.0
● Now $1.6 ● Target $6.58
TRADING DATA
Avg Volume 1.1M
YTD Return -0.6%
Analyst Count 6
Consensus Buy
Upside to Target +311.5%
Last Updated 2026-08-13

ANALYST SUMMARY

Codexis, Inc. (CDXS) is currently trading at $1.6 with a Wall Street consensus price target of $6.58, implying potential upside of 311.5% over the next 12 months. 6 analysts currently cover CDXS, with a consensus rating of Buy - 67% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $11.0, while the most cautious has a target of $2.0.

CDXS operates in the Healthcare sector with a market capitalisation of $172M. The stock is down 0.6% year-to-date and is currently trading near the lower end of its 52-week range of $0.96 – $3.87.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

ZVRA +118.5%
Zevra Therapeutics, Inc.
$679M · P/E 12.2x · Buy
TCMD +56.1%
Tactile Systems Technology, Inc.
$555M · P/E 22.9x · Buy
AGEN +182.6%
Agenus Inc.
$311M · P/E 2.3x · Buy
JYNT +15.2%
The Joint Corp.
$123M · P/E 62.0x · Hold
SLP -5.8%
Simulations Plus, Inc.
$371M · P/E 45.8x · Hold

RECENT ANALYST CALLS

Upgrade/downgrade history for CDXS, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Cantor Fitzgerald reit
Overweight → Overweight 2024-11-22 40% win rate (10 calls)
Cantor Fitzgerald reit
Overweight → Overweight 2024-11-15 40% win rate (10 calls)
Benchmark reit
Hold 2024-11-04 Building track record
Cantor Fitzgerald reit
Overweight → Overweight 2024-09-20 40% win rate (10 calls)
Cantor Fitzgerald reit
Overweight → Overweight 2024-08-29 40% win rate (10 calls)
Benchmark ↓ Downgrade
Buy → Hold 2024-08-19 Building track record
Cantor Fitzgerald reit
Overweight → Overweight 2024-08-09 40% win rate (10 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
29
out of 100
Coverage depth
15/30
Consensus clarity
0/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →